BK

Bikky Kumari Rai

Active Director Director DIN 08278653
DIN 08278653 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Bikky Kumari Rai

Data last updated:

Bikky Kumari Rai is a Director at Curofy Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Curofy Pharmaceuticals Private Limited reported revenue of ₹81.8 Lakh (FY 2025).

DIN 08278653
Primary Designation Director
Industry Pharma
First Appointment 13 Nov 2018
Oldest Company Age 7 yrs
Largest company Curofy Pharmaceuticals Private Limited · ₹81.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Nov 20182018₹81.8 Lakh (FY 2025)Active

Board colleagues of Bikky Kumari Rai

Directorship timeline

Open interactive timeline →
Curofy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bikky Kumari Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bikky Kumari Rai

Bikky Kumari Rai currently holds 1 directorship: Curofy Pharmaceuticals Private Limited (Director, since 13 Nov 2018, revenue ₹81.8 Lakh (FY 2025)).

Bikky Kumari Rai was first appointed on 13 Nov 2018 as Director at Curofy Pharmaceuticals Private Limited.

The current boards of Bikky Kumari Rai's companies include Amandeep Singh (Curofy Pharmaceuticals Private Limited), Roshan Kumar (Curofy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available